Literature DB >> 12433031

Diabetic ketoacidosis and persistent hyperglycemia as long-term complications of L-asparaginase-induced pancreatitis.

Yu-Juei Hsu1, Yeu-Chin Chen, Ching-Liang Ho, Woei-Yau Kao, Tsu-Yi Chao.   

Abstract

Diabetic ketoacidosis (DKA) and pancreatic pseudocysts are rare complications following treatment of hematological malignancies with L-asparaginase (L-asp). Persistent hyperglycemia with recurrent DKA presenting as a long-term complication of L-asp-induced pancreatitis is even rarer. A 21-year-old man with pre-B-type acute lymphoblastic leukemia (ALL) developed pancreatic pseudocysts, DKA and persistent hyperglycemia after L-asp therapy. The patient was treated with oral hypoglycemic agents (OHA) for sugar control thereafter. Ten months later, another episode of DKA developed during relapsed ALL without having obvious precipitating factors. Insulin was then instituted for control of his blood sugar until death. The leukemic process may play some role in glucose homeostasis and may be considered as a precipitating factor for DKA. The patient finally died of disease progression of ALL and sepsis 2 years after the initial diagnosis of ALL.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12433031

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi (Taipei)        ISSN: 0578-1337


  4 in total

Review 1.  Drug-Induced Hyperglycaemia and Diabetes.

Authors:  Neila Fathallah; Raoudha Slim; Sofien Larif; Houssem Hmouda; Chaker Ben Salem
Journal:  Drug Saf       Date:  2015-12       Impact factor: 5.606

2.  Characteristics of chemotherapy-induced diabetes mellitus in acute lymphoblastic leukemia patients.

Authors:  Shan-Shan Suo; Chen-Ying Li; Yi Zhang; Jing-Han Wang; Yin-Jun Lou; Wen-Juan Yu; Jie Jin
Journal:  J Zhejiang Univ Sci B       Date:  2020 Sept.       Impact factor: 3.066

3.  L-asparaginase-induced abnormality in plasma glucose level in patients of acute lymphoblastic leukemia admitted to a tertiary care hospital of Odisha.

Authors:  Mousumee Panigrahi; Trupti Rekha Swain; Rabindra Kumar Jena; Ashutosh Panigrahi
Journal:  Indian J Pharmacol       Date:  2016 Sep-Oct       Impact factor: 1.200

4.  Diabetic ketoacidosis following PEG-asparaginase therapy

Authors:  Miriam Hinaa Ahmad; Ismat Shafiq
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2018-10-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.